Improved Shared Decision-making for Patients with Renal Cell Carcinoma: Results of the SDM-RCC Study [0.03%]
改善肾细胞癌患者的共同决策：SDM-RCC研究的结果
Cato C Bresser,Mirjam M Garvelink,Tessa van Dijk et al.
Cato C Bresser et al.
Background and objective: To improve shared decision-making (SDM) for renal cell carcinoma (RCC), we implemented an SDM intervention consisting of a patient decision aid and health care professional (HCP) training. This s...
Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study [0.03%]
高容量骨转移性激素敏感前列腺癌患者的双联疗法与三联疗法对比：ARON-3研究结果
Philipp Cornelius Mandel,Mike Wenzel,María Natalia Gandur Quiroga et al.
Philipp Cornelius Mandel et al.
Background and objective: Data for direct comparison of the outcomes for androgen-deprivation therapy (ADT) + androgen signaling pathway-inhibitors (ARPI) versus ADT + ARPI + docetaxel are scant, especially in patients wi...
Reply to Selcuk Guven, Selim Soyturk, and Thomas Herrmann's Letter to the Editor re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15: My Vision for the Novel Trans [0.03%]
Selcuk Guven、Selim Soyturk和Thomas Herrmann来信评论Jeremy Y. Teoh等文章“VIABLE试验第一阶段：新型经尿道机器人平台整体切除膀胱肿瘤的疗效”的回复我的关于这一创新性经尿道机器人手术平台愿景
Jeremy Yuen-Chun Teoh
Jeremy Yuen-Chun Teoh
Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study Protocol [0.03%]
前列腺癌可疑情况的序贯影像诊断：及时诊断出有意义癌症，减少过度诊断和不必要的活检（SPROUT）——前瞻性多中心队列研究方案
V Sweere,M de Rooij,P J M Kil et al.
V Sweere et al.
Background and objective: Overdiagnosis of clinically insignificant prostate cancer (International Society of Urological Pathology Grade Group 1 [ISUP GG1]) remains a concern. Many men with Prostate Imaging Reporting and ...
Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer [0.03%]
膀胱癌诊断后成功戒烟对生存的影响
Landan P MacDonald,George Kypriotakis,Maher Karam-Hage et al.
Landan P MacDonald et al.
Background and objective: Smoking is the strongest modifiable risk factor for the development of bladder cancer. The benefits of smoking abstinence following a bladder cancer diagnosis are uncertain. Our objective was to ...
Comparative Outcomes of Robot-assisted versus Open Radical Nephrectomy with IVC Thrombectomy in France: Insights from the Robocav Study (UroCCR 188) [0.03%]
来自法国机器人与开放手术取肾联合腔静脉切开术的比较结果：Robocav研究（UroCCR 188）的新观点
Jean Tournant,Gaëlle Margue,Franck Bruyere et al.
Jean Tournant et al.
Background: While robotic-assisted radical nephrectomy with IVC thrombectomy (R-CT) has emerged as a minimally invasive alternative to the open approach (O-CT), the latter remains the standard, with limited comparative st...
MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial [0.03%]
前列腺癌筛查中的MRI质量和阅读者经验：PROBASE试验的启示
Matthias Boschheidgen,Rouvier Al-Monajjed,Heinz-Peter Schlemmer et al.
Matthias Boschheidgen et al.
Background: The diagnostic performance of prostate magnetic resonance imaging (MRI) critically depends on image quality and reader expertise. The PROBASE trial is a prospective population- and prostate-specific antigen (P...
Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus [0.03%]
BCG无应答非肌层浸润性膀胱癌的治疗需求及比较证据生成挑战：专家共识
Paolo Gontero,Richard Perry,Daisy Bridge et al.
Paolo Gontero et al.
Background and objective: The overall objective of this modified Delphi panel study was to develop a consensus of European expert clinical opinion on unmet need, clinical evidence generation, and appropriate trial endpoin...
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy [0.03%]
AI-MIRACLE：人工智能和多参数MRI预测新辅助免疫治疗后接受根治性膀胱切除术的肌层浸润性膀胱癌患者的临床结局
Andrea Necchi,Giorgio Brembilla,Karissa Whiting et al.
Andrea Necchi et al.
Background and objective: Neoadjuvant immune-checkpoint inhibitors (ICIs) in muscle-invasive bladder cancer (MIBC) were tested in patient's ineligible for cisplatin-based chemotherapy. The PURE-01 trial (NCT02736266) eval...
EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer [0.03%]
EZH2抑制可重塑细胞类型并增强膀胱癌对EGFRi的敏感性
Hongda Zhao,Jinyue Liao,Ho Vincy Wing Sze et al.
Hongda Zhao et al.
Background: Bladder cancer (BCa) displays interpatient heterogeneity and epigenetic plasticity that may limit treatment efficacy. Objective: ...